NEW YORK (GenomeWeb) – DNA Script announced today that it has acquired an exclusive license from Dynamic Combinatorial Chemistry (DCC) to a novel DNA building block for use in enzymatic DNA synthesis.
The building blocks, which were initially developed by DCC affiliate Firebird Biomolecular Sciences, are reversible terminator nucleotides with cleavable protective groups that help in controlling the enzymatic synthesis process, according to DNA Script COO Sylvain Gariel.